Suppr超能文献

服用圣约翰草(金丝桃素)会增强高剂量紫外线A1疗法期间的红斑反应吗?

Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?

作者信息

Beattie P E, Dawe R S, Traynor N J, Woods J A, Ferguson J, Ibbotson S H

机构信息

Photobiology Unit, Dermatology Department, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, U.K.

出版信息

Br J Dermatol. 2005 Dec;153(6):1187-91. doi: 10.1111/j.1365-2133.2005.06946.x.

Abstract

BACKGROUND

St John's wort (SJW) is widely used as a treatment for depression. A phototoxic reaction, due to its content of hypericin, can occur in animals and in cell culture, and has been reported in humans. Hypericin displays absorption within the ultraviolet (UV) A1 spectrum and there may therefore be a potential for phototoxicity if taken during high-dose UVA1 therapy.

OBJECTIVES

To assess the phototoxicity risk of SJW ingestion.

METHODS

Eleven adult volunteers of skin types I and II were exposed to a geometric dose series of UVA1 irradiation from a high-output source (Dermalight Ultra 1; Dr Hönle, Martinsreid, Germany; irradiance 70-77 mW cm(-2)) on the photoprotected lower back skin at eight 1.5-cm(2) test areas. Irradiation was carried out at baseline and after 10 days of SJW extract 1020 mg (equivalent to 3000 microg of hypericin) daily. Four, 8, 24 and 48 h after each exposure, the minimal erythema dose (MED) and the presence or absence of pigmentation were recorded visually and erythema was assessed objectively with an erythema meter.

RESULTS

The median MED and D(0.025), an objective measure of MED, were lower at all time-points after SJW ingestion. The visual erythemal peak (lowest median MED), which was seen at 8 h postirradiation, was lower after SJW (median 14 J cm(-2), range 10-56) than at baseline (median 20 J cm(-2), range 14-56) (P = 0.047). Similarly, the median D(0.025) at 8 h postirradiation was lower after SJW (median 22.0 J cm(-2), range 15.2-53.9) than at baseline (median 33.7 J cm(-2), range 22.9-136.0) (P = 0.014). The MED and D(0.025) were also significantly different at the 48-h and 4-h time-points, respectively. Significance was not reached at the 24-h time-point. Median intensity of postirradiation erythema increased at all time-points after ingestion of SJW. Despite these differences, the maximum slope of the dose-response curve was not increased after SJW ingestion.

CONCLUSIONS

These data suggest that SJW extract has the potential to lower the erythemal threshold to UVA1 irradiation in a significant proportion of individuals and highlight the importance of ascertaining a full drug history, including herbal remedies, before initiating UVA1 phototherapy.

摘要

背景

圣约翰草广泛用于治疗抑郁症。由于其含有金丝桃素,在动物和细胞培养中可发生光毒性反应,在人类中也有相关报道。金丝桃素在紫外线A1光谱范围内有吸收,因此在高剂量紫外线A1治疗期间服用可能存在光毒性风险。

目的

评估摄入圣约翰草的光毒性风险。

方法

11名I型和II型皮肤的成年志愿者在背部下方光保护皮肤的8个1.5平方厘米测试区域,接受来自高输出光源(Dermalight Ultra 1;德国马丁斯赖德的Hönle博士公司;辐照度70 - 77毫瓦/平方厘米)的紫外线A1照射的几何剂量系列。在基线时以及每天服用1020毫克圣约翰草提取物(相当于3000微克金丝桃素)10天后进行照射。每次照射后4、8、24和48小时,目测记录最小红斑剂量(MED)以及色素沉着情况,并用红斑仪客观评估红斑。

结果

摄入圣约翰草后,所有时间点的MED中位数和作为MED客观测量指标的D(0.025)均较低。照射后8小时出现的视觉红斑峰值(最低MED中位数),圣约翰草组(中位数14焦/平方厘米,范围10 - 56)低于基线(中位数20焦/平方厘米,范围14 - 56)(P = 0.047)。同样,照射后8小时的D(0.025)中位数,圣约翰草组(中位数22.0焦/平方厘米,范围15.2 - 53.9)低于基线(中位数33.7焦/平方厘米,范围22.9 - 136.0)(P = 0.014)。MED和D(0.025)在48小时和4小时时间点也分别有显著差异。在24小时时间点未达到显著性差异。摄入圣约翰草后,所有时间点照射后红斑的中位数强度均增加。尽管存在这些差异,但摄入圣约翰草后剂量反应曲线的最大斜率并未增加。

结论

这些数据表明,圣约翰草提取物在很大一部分个体中有可能降低对紫外线A1照射的红斑阈值,并突出了在开始紫外线A1光疗前确定完整用药史(包括草药疗法)的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验